Procaps Group Sa Stock Beta
| PROC Stock | USD 1.11 0.54 94.74% |
Procaps Group SA fundamentals help investors to digest information that contributes to Procaps Group's financial success or failures. It also enables traders to predict the movement of Procaps Stock. The fundamental analysis module provides a way to measure Procaps Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Procaps Group stock.
Procaps | Beta |
Procaps Group SA Company Beta Analysis
Procaps Group's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Procaps Group Beta | 0.17 |
Most of Procaps Group's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procaps Group SA is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Procaps Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Procaps Group is extremely important. It helps to project a fair market value of Procaps Stock properly, considering its historical fundamentals such as Beta. Since Procaps Group's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Procaps Group's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Procaps Group's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Procaps Group SA has a Beta of 0.167. This is 80.58% lower than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Procaps Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procaps Group's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procaps Group could also be used in its relative valuation, which is a method of valuing Procaps Group by comparing valuation metrics of similar companies.Procaps Group is currently under evaluation in beta category among its peers.
Procaps Group Institutional Holders
Institutional Holdings refers to the ownership stake in Procaps Group that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Procaps Group's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Procaps Group's value.| Shares | Exome Asset Management Llc | 2024-06-30 | 126.9 K | Geode Capital Management, Llc | 2024-06-30 | 28.9 K | State Street Corp | 2024-06-30 | 12.4 K | Activest Wealth Management | 2024-06-30 | 10 K | Royal Bank Of Canada | 2024-06-30 | 491 | Pineridge Advisors Llc | 2024-09-30 | 250 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 200 | Renaissance Technologies Corp | 2024-06-30 | 0.0 | Ubs Group Ag | 2024-06-30 | 0.0 |
As returns on the market increase, Procaps Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding Procaps Group is expected to be smaller as well.
Procaps Fundamentals
| Return On Equity | 0.37 | ||||
| Return On Asset | 0.0628 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 389.32 M | ||||
| Shares Outstanding | 112.82 M | ||||
| Shares Owned By Insiders | 83.02 % | ||||
| Shares Owned By Institutions | 2.81 % | ||||
| Number Of Shares Shorted | 20.49 K | ||||
| Price To Book | 3.18 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 414.1 M | ||||
| Gross Profit | 191.31 M | ||||
| EBITDA | 57.06 M | ||||
| Net Income | 52.2 M | ||||
| Cash And Equivalents | 37.55 M | ||||
| Cash Per Share | 0.37 X | ||||
| Total Debt | 285.94 M | ||||
| Debt To Equity | 6.02 % | ||||
| Current Ratio | 1.54 X | ||||
| Book Value Per Share | 0.39 X | ||||
| Cash Flow From Operations | 62.99 M | ||||
| Short Ratio | 1.65 X | ||||
| Earnings Per Share | 0.51 X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 5.5 K | ||||
| Beta | 0.17 | ||||
| Market Capitalization | 125.23 M | ||||
| Total Asset | 460.19 M | ||||
| Retained Earnings | (391.51 M) | ||||
| Working Capital | (70.93 M) | ||||
| Net Asset | 460.19 M |
About Procaps Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procaps Group SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procaps Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procaps Group SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Procaps Group SA is a strong investment it is important to analyze Procaps Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Procaps Group's future performance. For an informed investment choice regarding Procaps Stock, refer to the following important reports:Check out Procaps Group Piotroski F Score and Procaps Group Altman Z Score analysis. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Procaps Group. If investors know Procaps will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Procaps Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.64) | Earnings Share 0.51 | Revenue Per Share 4.097 | Quarterly Revenue Growth 0.073 | Return On Assets 0.0628 |
The market value of Procaps Group SA is measured differently than its book value, which is the value of Procaps that is recorded on the company's balance sheet. Investors also form their own opinion of Procaps Group's value that differs from its market value or its book value, called intrinsic value, which is Procaps Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Procaps Group's market value can be influenced by many factors that don't directly affect Procaps Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Procaps Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Procaps Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Procaps Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.